- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
ZIM Laboratories' manufacturing facility failed its EU Good Manufacturing Practices (GMP) inspection by German and Portuguese authorities, indicating non-compliance. The inspection identified 2 critical, 8 major, and 18 minor deficiencies. The company must submit a corrective action plan within four weeks. A re-inspection will follow to verify resolution. This is a significant operational setback, potentially impacting future European market access and requiring immediate attention to restore compliance standards. Investors should monitor progress closely.